Polypill strategy at the heart of cardiovascular secondary prevention
- PMID: 30030331
- DOI: 10.1136/heartjnl-2018-313464
Polypill strategy at the heart of cardiovascular secondary prevention
Keywords: acute myocardial infarction; cardiac risk factors and prevention; medication adherence; stroke.
Conflict of interest statement
Competing interests: BI and VF have no personal conflicts of interest to declare. JMC has received speaker fees and travel support from Ferrer. The CNIC is a non-profit public institution that receives royalties for the sales of a polypill (Trinomia) composed of aspirin, ramipril and atorvastatin, but no CNIC researcher has direct interests or receives any personal benefits.
Comment on
-
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials.Heart. 2019 Jan;105(1):42-48. doi: 10.1136/heartjnl-2018-313108. Epub 2018 Jun 28. Heart. 2019. PMID: 29954855
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources